Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1

Pediatric Infectious Disease Journal

Volumn 16, Issue 12, 1997, Pages 1177-1178

  Sibailly, Toussaint S ^a   Wiktor, Stefan Z ^a,c   Tsai, Theodore F ^d   Cropp, Bruce C ^d   Ekpini, Ehounou R ^a   Adjorlolo Johnson, Georgette ^a   Gnaore, Emannuel ^b   DeCock, Kevin M ^c   Greenberg, Alan E ^a,c  

^a Project RETRO CI Abidjan   (Côte d’Ivoire)

^b National AIDS Control Program   (Côte d’Ivoire)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Africa; Cote d'Ivoire; Human; Immunodeficiency virus type 1; Immunologic response; Vaccination; Yellow fever

Indexed keywords

MEASLES VACCINE; VIRUS ANTIBODY; YELLOW FEVER VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COTE D'IVOIRE; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERINATAL INFECTION; PRIORITY JOURNAL; VACCINATION; YELLOW FEVER;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, VIRAL; FEMALE; HIV-1; HUMANS; INFANT; MALE; VACCINATION; VIRAL VACCINES; YELLOW FEVER VIRUS;

EID: 0031469306     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199712000-00015     Document Type: Article

References (11)

1. Katz SL. Immunizations for HIV-infected children. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. Baltimore: Williams & Wilkins, 1994:859-67.
2. Gayle HD, Gnaore E, Adjorlolo G, et al. HIV-1 and HIV-2 infection in children in Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr 1992;5:513-7.
3. Vetter KM, Djomand G, Zadi F, et al. Clinical spectrum of human immunodeficiency virus disease in children in a West African City. Pediatr Infect Dis J 1996;15:438-42.
4. Freestone DS. Yellow fever vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccine. 2nd ed. Philadelphia: Saunders, 1994:741-79.
5. Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of HIV-1 and HIV-2 perinatal transmission in Abidjan, Ivory Coast. JAMA 1994;272:462-88.
6. De Cock KM, Porter A, Kouadio J, et al. Rapid and specific diagnosis of HIV-1 and HIV-2 infections: an evaluation of testing strategies. AIDS 1990;4:875-8.
7. Tsai TF. Arboviruses. In: Murrary PR, Baron EJ, Pfaller MA, Tenover FC, Yoken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:980-96.
8. World Health Organization. Provisional clinical case definition for AIDS. Wkly Epidemiol Rec 1986;61:72-3.
9. Smith HH, Penna HA, Paoliello A. Yellow fever vaccination with cultured virus (17D) without immune serum. Am J Trop Med 1938;18:437-68.
10. Brena AE, Cooper ER, Cabrai HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr 1993;6:1125-9.
11. Rutstein RM, Rudy B, Codispoti C, Watson B. Response to hepatitis B immunization by infants exposed to HIV. AIDS 1994;8:1281-4.